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Yeast mitochondriaThe yeast cytochrome bc1 complex, a component of the mitochondrial respiratory chain, is composed of ten
distinct protein subunits. In the assembly of the bc1 complex, some ancillary proteins, such as the chaperone
Bcs1p, are actively involved. The deletion of the nuclear gene encoding this chaperone caused the arrest of
the bc1 assembly and the formation of a functionally inactive bc1 core structure of about 500-kDa. This
immature bc1 core structure could represent, on the one hand, a true assembly intermediate or, on the other
hand, a degradation product and/or an incorrect product of assembly. The experiments here reported show
that the gradual expression of Bcs1p in the yeast strain lacking this protein was progressively able to rescue
the bc1 core structure leading to the formation of the functional homodimeric bc1 complex. Following Bcs1p
expression, the mature bc1 complex was also progressively converted into two supercomplexes with the
cytochrome c oxidase complex. The capability of restoring the bc1 complex and the supercomplexes was also
possessed by the mutated yeast R81C Bcsp1. Notably, in the human ortholog BCS1L, the corresponding point
mutation (R45C) was instead the cause of a severe bc1 complex deﬁciency. Differently from the yeast R81C
Bcs1p, two other mutated Bcs1p's (K192P and F401I) were unable to recover the bc1 core structure in yeast.
This study identiﬁes for the ﬁrst time a productive assembly intermediate of the yeast bc1 complex and gives
new insights into the molecular mechanisms involved in the last steps of bc1 assembly.0p, subunits 6, 7, 8, 9, and 10 of
6b of the yeast cytochrome c
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The cytochrome bc1 complex (or complex III), a component of the
mitochondrial respiratory chain, is located in the inner mitochon-
drial membrane where it acquires a dimeric form. Each monomer is
composed of eleven subunits in mammals and of 10 subunits in the
yeast Saccharomyces cerevisiae [1–4]. Three protein subunits,
cytochrome b, cytochrome c1, and the iron–sulphur protein (ISP),
play a catalytic role and each of them contains speciﬁc redox centers.
The remaining subunits (eight in mammals and seven in yeast) do
not contain any prosthetic group and are not directly involved in the
catalytic process of electron transport and proton pumping. Their
function, indeed, is largely unknown. Moreover, cytochrome b is the
only subunit encoded by mitochondrial DNA, whereas all the others
are encoded by nuclear DNA. Interestingly, several studies havedemonstrated the association of complex III with other complexes of
the mitochondrial respiratory chain-forming molecular structures
named supercomplexes or respirasomes [5–8].
By taking into account the fact that the mature and functional
cytochrome bc1 complex is a dimer, and also that each monomer
includes at least 10 different protein subunits whose expression is
controlledbybothmitochondrial and nuclearDNA,we can infer that the
process of assembly of this mitochondrial respiratory chain complex is
quite intricate. Up to now, the assembly pathway of the cytochrome bc1
complex has been elucidated only in part, and most of the experiments
have been carried out in yeast mitochondria. Several lines of evidence
suggest that a multistep process occurs during the assembly of this
complex in the inner mitochondrial membrane, thereby leading to the
proposal of a putative model of assembly in which the participation of
distinct bc1 subcomplexes has been hypothesized [4,7,9–12]. Very
recently, a large core structure of about 500-kDa has been identiﬁed and
repeatedly found in distinct yeastmutant strains inwhich genes for one
or more of the cytochrome bc1 complex subunits had been deleted [8].
As expected, this immature form of the bc1 complex was not functional
because of the lack of some protein subunits (Qcr9p, ISP, and Qcr10p). It
is possible that it may represent, on the one hand, a true assembly
intermediate of the cytochrome bc1 complex or, on the other hand, a
degradation product or an incorrectly assembled intermediate in the
various yeast deletionmutants studied. The assembly of the cytochrome
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protein, named Bcs1p in yeast and BCS1L in human,which is involved in
the insertion of ISP into an immature bc1 complex [13–15]. Very
interestingly, a mutant yeast strain in which the nuclear gene encoding
Bcs1p had been deleted (ΔBCS1) showed the presence of the large bc1
core structure of 500-kDa [8].
In the sequence of both Bcs1p and BCS1L at least three different
domains can be identiﬁed, themost studied onebeing theAAA (ATPases
associated with a variety of cellular activities) domain. The members of
the AAA family usually exist as oligomers and participate in various
reactions, such as folding, unfolding, assembly and degradation of other
proteins [16]. Several point mutations have been identiﬁed in distinct
regions of human BCS1L. They are responsible for various biochemical
alterations, such as bc1 complex activity impairment, increased
production of reactive oxygen species and iron overload. As a
consequence, distinct clinical manifestations have been described
ranging from the most severe case, the GRACILE syndrome [17,18]
characterized by fetal growth retardation, aminoaciduria, cholestasis,
iron overload, lactic acidosis, and early death, to many bc1 complex
deﬁciencies characterized by various neuromuscolar disorders, enceph-
alopathy, and sometimes visceral symptoms [19–22] and, ﬁnally, to the
least severe Björnstad syndrome [23] with sensorineural hearing loss
and pili torti. Intermediate clinical manifestations have also been
described [24]. Because of sequence similarity between the yeast Bcs1p
and human BCS1L (50% identity), several mutated sequences of human
BCS1L have been expressed in a yeast strain lacking the endogenous
yeast Bcs1p to assess the pathogenic role of single point mutations.
Furthermore, although the role of yeast Bcs1p in the late steps of bc1
complex maturation has already been established [15], several doubts
still exist on themolecularmechanisms of interaction of this chaperone
with the immature bc1 complex.
In this study, we have expressed the wild type Bcs1p in a ΔBCS1
mutant strain to monitor, at a molecular level, the structural changes
occurring in the 500-kDa bc1 subcomplex previously found in this
yeast deletion strain. We then expressed in the ΔBCS1 strain some
mutated yeast Bcs1p's in which distinct amino acid substitutions,
corresponding to the parallel pathogenic mutations found in human
BCS1L, have been introduced. These experiments were carried out
with the aim of gaining new insights into the role of these amino acid
residues which are present in critical and conserved regions both in
the human BCS1L and in the yeast Bcs1p.2. Materials and methods
2.1. Chemicals
Yeast extract and bacto-peptone were purchased from Difco
(Detroit, MI, USA). Cycloheximide, digitonin, yeast nitrogen base
without amino acids, phenylmethylsulfonyl ﬂuoride, Triton X-100,
glass beads, acrylamide, bis-acrylamide, N,N,N′N′-tetramethylethyle-
nediamine (TEMED), ammonium peroxodisulfate, 6-aminohexanoic
acid, di-isopropylﬂuorophosphate, agar, glucose, molecular weight
protein markers for electrophoresis, glycerol, and oligonucleotides for
PCR were obtained from Sigma (St Louis, MO, USA). Tricine was from
USB (Cleveland, OH, USA). Nitrocellulose was from Pall Life Sciences
(New York, NY, USA). Bis–Tris, ULTROL grade, was from CalbiochemTable 1
Primer sequences used in this study.
Gene Forward primer 5′–3′ (Tm)
BCS1(gene ID: 851981) TCTACCATGTCGGATAAGCC (62 °C)
ISP(gene ID: 856689) CAAACATGTTAGGAATAAGATCATC
QCR9(gene ID: 853095) AAAATGTCTTTTTCATCACTATATAA(La Jolla, CA, USA). Coomassie Brilliant Blue G-250 was from Serva
(Heidelberg, Germany). The ECL Plus Western Blotting detection
system for Western blotting was from Amersham Biosciences
(Chalfont St Giles, UK). Platinum® Taq DNA Polymerase High Fidelity,
pYES2.1 TOPO TA Expression Kit, and GeneTailor™ Site-directed
Mutagenesis System were purchased from Invitrogen (Carlsbad, CA,
USA). Easy tag EXPRESS 35S Protein Labelling Mix was from Perkin
Elmer Life Sciences, Waltham, MA, USA. All other reagents were of
analytical grade.
2.2. Strains, vectors, and growth media
The wild-type yeast strain W303 and the ΔBCS1 mutant strain
were a generous gift from A. Tzagoloff (Columbia University,
New York, NY, USA). The bacterial strain utilized for cloning and
genetic manipulations was Escherichia coli TOP10F′, under ampicillin
selection (Invitrogen, Carlsbad, CA, USA). The pYES2.1/V5-His-TOPO®
vector was used to insert the yeast BCS1 gene and mutant versions,
according to the manufacturer's instructions. For the isolation of
mitochondrial membranes, the yeast strains were grown at 25 °C in
YPD medium containing 1% (wt./vol.) yeast extract, 2% (wt./vol.)
bacto-peptone, and 2% (wt./vol.) glucose, pH 5.0. The recombinant
yeast strains were selected and maintained at 30 °C in the minimal
medium YNB-U, containing 6.7 g/l yeast nitrogen base, 1.92 g/l drop-
out without uracil and 2% (wt./vol.) glucose. E. coli cells were grown in
Luria–Bertani medium (LB) [0.5% (wt./vol.) yeast extract, 1% (wt./vol.)
bacto-tryptone, 1% (wt./vol.) NaCl], supplemented with 100 μg/mL
ampicillin.
2.3. Cloning and site-directed mutagenesis procedures
The S. cerevisiae BCS1, ISP, and QCR9 genes were ampliﬁed by PCR
from genomic DNAwith speciﬁc primers (Table 1). After a denaturing
step at 94 °C for 2 min, ampliﬁcation was performed for 35 cycles of
denaturation, annealing, and extension, respectively, as follows: BCS1,
94 °C/60 s, 59 °C/45 s, 68 °C/90 s; QCR9, 94 °C/45 s, 58 °C/90 s, 68 °C/
40 s; ISP, 94 °C/30 s, 59 °C/30 s, 68 °C/45 s. Final synthesis was always
at 68 °C for 10 min. The PCR products were separated on 1% agarose
gel, and the DNA in the discrete bands was extracted with the
QIAquick Gel Extraction Kit (Qiagen, San Diego, CA, USA) according to
the manufacturer's protocol. The PCR products were then cloned into
the yeast expression vector pYES2.1/V5-His-TOPO®, containing the
galactose-inducible glucose-repressible GAL1 promoter, giving
pYES2.1/V5-His-TOPO/BCS1wt, pYES2.1/V5-His-TOPO/ISP, and
pYES2.1/V5-His-TOPO/QCR9 clones, respectively. Individual recombi-
nant clones were analyzed by restriction analysis and sequencing to
screen the identity and the correct orientation of the inserts in the
pYES2.1/V5-His-TOPO® vector.
Yeast BCS1 mutant versions were constructed by GeneTailor™
Site-directed Mutagenesis System, as per manufacturer's protocol.
BCS1R81C was synthesized by using pYES2.1/V5-His-TOPO/BCS1wt
as a template and the oligonucleotide pair 5′-AAGCCAGCAGGGT-
CCTATACTGCCAAATGATTG-3′ and 5′-GTATAGGACCCTGCTGGCTTT-
TATTATACC-3′. BCS1K192P was obtained from pYES2.1/V5-His-TOPO/
BCS1wt by site-directed mutagenesis, using the oligonucleotide
pair 5′-ATGACATTTTGAACGAGGCTCCAGACATAGCCC-3′ and 5′-Reverse primer 5′–3′ (Tm)
GCGCCACTTAGCACCTAGAA (64 °C)
TG (62 °C) CAAACCTAACCAACAATGACC (60 °C)
AACC (62 °C) TTACTCATCATCGTCGTCTCCATCG (70 °C)
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V5-His-TOPO/BCS1wt by using the oligonucleotide pair 5′-TAGAAAA-
AATGTTTATGAAAATTTACCCAGGTG-3′ and 5′-TTTCATAAACATTTTTTC-
TACCTGGTATGG-3′ resulted in the creation of BCS1F401I. All mutations
were conﬁrmed by DNA sequencing and restriction analysis.
2.4. Yeast transformation and expression
S. cerevisiae deletion strain ΔBCS1 was used as host for the various
recombinant expression vectors. Yeast transformationswereperformed
by treatmentwith lithiumacetate [25], and the transformantswere then
selected and maintained on minimal medium YNB-U (yeast nitrogen
base without uracil). For protein expression, recombinant yeast strains
were grown overnight in 800 mL of YPD to the exponential growth
phase and were then transferred in the same medium containing
galactose 2% wt./vol. instead of glucose, to induce Bcs1p expression.
Cells were then harvested at 0, 1, 2, and 4 h after induction and
subsequently analyzed, as described below.
2.5. Determination of growth phenotype
The growth phenotype was determined by incubating yeast cells
either on YPD [1% (wt./vol.) yeast extract, 2% (wt./vol.) bacto-peptone,
2% (wt./vol.) agar and 2% (wt./vol.) glucose] or on YPEG plates [1%
(wt./vol.) yeast extract, 2% (wt./vol.) bacto-peptone, 2% (wt./vol.) agar,
3% (vol./vol.) glycerol and 2% (vol./vol.) ethanol].
2.6. Isolation of mitochondrial membranes
Mitochondrial membranes were isolated from yeast strains essen-
tially as described previously [12]. Brieﬂy, yeast cells were grown
overnight at 25 °C in 800 mLof YPDuntil exponential growthphasewas
reached (OD578 of 1–2); in the case of recombinant yeast, protein
expression was induced as previously described. Cells were recovered
by centrifugation at 3200×g for 15 min (Avanti J-E centrifuge, JA-14
rotor; Beckman Coulter, Fullerton, CA, USA), washed once with distilled
water and then resuspended in 25 mLofMTE buffer (400 mMmannitol,
50 mM Tris–HCl, 2 mM EDTA, pH 7.4). Acid-washed glass beads were
added up to a ﬁnal volume of 30 mL to the mixture kept at 4 °C. Then,
1 mM di-isopropylﬂuorophosphate was added to prevent nonspeciﬁc
proteolytic degradation. Afterwards, the cellswere brokenmechanically
with a vortex mixer at maximum speed for 10 min at 4 °C. After the
further addition of MTE buffer to a ﬁnal volume of 50 mL, the mixture
was vortexedbrieﬂy and then centrifuged at 1000×g for 10 min (Avanti
J-E centrifuge, JA-14 rotor). The pellet was discarded, while the
supernatant was transferred to a fresh tube and recentrifuged at
18,500×g for 30 min (5810R centrifuge, F-34-6-3 rotor; Eppendorf,
Hamburg, Germany) to pellet themitochondrial membranes. The pellet
was then washed with 20–30 mL of MTE buffer and reisolated by
centrifugation as described above. The mitochondrial membranes were
ﬁnally resuspended in 1 mL of MTE buffer, divided in aliquots of 50 μL
each, and stored at−80 °C.
2.7. Measurement of ubiquinol cytochrome c reductase activity
Complex III activity was determined bymeasuring the reduction of
oxidized cytochrome c at 550 nm.Mitochondrial membranes from the
various yeast strains were incubated for 1 min at 30 °C in a reaction
medium containing 50 mM potassium phosphate (pH 7.2), 0.01%
(wt./vol.) Tween-20, EDTA 50 μM, 4 mM KCN, and 40 μM oxidized
cytochrome c. The reaction was initiated by adding the ubiquinol
analog, decylubiquinol (DBH2), to a ﬁnal concentration of 50 μM,
and the rate of cytochrome c reduction was calculated from the
absorbance increase at 550 nm.2.8. Labelling of mitochondrial encoded proteins
Mitochondrial translation products were speciﬁcally labelled using
previously employed methods, with minor modiﬁcations [26–28].
Yeast cells were grown in the minimal medium YNB-U to an OD578 of
0.5 to 2.0. Cycloheximide (0.2 mg/mL)was added to block cytoplasmic
protein synthesis. Afterwards, cells were labelled with 40 μCi of [35S]
methionine/cysteine (11 mCi/mL) for 15 min at 30 °C. After a chase
with 4 mM cold methionine, cells were harvested (0 h) or chased for
1 h and 4 h along with a concomitant induction of Bcs1p expression.2.9. Electrophoretic techniques
Mitochondrial membranes were analyzed by standard SDS–PAGE
with 15% (wt./vol.) acrylamide and an acrylamide/bis-acrylamide
ratio of 30:0.8 (wt./wt.) [29].
In the blue native polyacrylamide gel electrophoresis (BN–PAGE),
the mitochondrial membranes (75 μg) were lysed in 50 μL of ice-cold
solubilization buffer [20 mM Tris–HCl, pH 7.4, 0.1 mM EDTA, 50 mM
NaCl, 10% (wt./vol.) glycerol, and 1 mMPMSF] containing 1% digitonin
(wt./vol.) for 10 min at 0 °C. After a clarifying centrifugation at
20,000×g for 30 min (5810 centrifuge, F-45-30-11 rotor) to remove
insoluble material, 2.5 μL of sample buffer (5% Coomassie Brilliant
Blue G-250, 100 mM Bis–Tris, pH 7.0, 500 mM 6-aminohexanoic acid)
was added to the supernatant. The BN–PAGE was then performed as
previously reported [7,30].
For subunit analysis of native complexes, sample lanes from
BN–PAGE were excised from the gel and incubated in a solution
containing 60 mM Tris–HCl (pH 6.8) and 0.2% SDS for 20 min at room
temperature; each gel strip was then placed horizontally in the gel-
pouring apparatus for the second dimension (SDS–PAGE), already
containing the separating gel. The gel slicewas subsequently encased in
5%polyacrylamide stacking gel andﬁnally submitted to electrophoresis.
High-molecular mass calibration markers used in the BN–PAGE
included thyroglobulin (670-kDa), apoferritin (440-kDa), catalase
(230-kDa), alcohol dehydrogenase (150-kDa), conalbumin (78-kDa),
albumin (66-kDa), and β-lactoglobulin (35-kDa). The calibration
markers used in the SDS–PAGE were albumin (66-kDa), ovalbumin
(45-kDa), glyceraldehyde 3-phosphate dehydrogenase (36-kDa),
carbonic anhydrase (29-kDa), trypsinogen (24-kDa), trypsin inhibitor
(20.1-kDa), and α-lactoglobulin (14.2-kDa).2.10. Western blotting and ECL detection
After electrophoresis, themitochondrial proteinswere transferred to
nitrocellulose by Western blotting following standard procedures.
Immunodetection was performed using polyclonal and monoclonal
primary antibodies against the various subunits of the yeast cytochrome
bc1 complex. The anti-Bcs1p Igs were a generous gift from R. Stuart
(Marquette University, Milwaukee,WI, USA). The secondary antibodies
wereperoxidase-conjugated anti-rabbit IgG (Chemie, Rockford, IL, USA)
or anti-mouse IgG (Amersham Biosciences, Chalfont St Giles, UK).
Immunodetection was performed by the ECL kit, and the ﬂuorographs
containing the immunodetected proteins were scanned and quantiﬁed
using an Imaging Densitometer GS-700 from Bio-Rad (Hercules, CA,
USA).2.11. Other methods
Protein concentrations were determined by the Bradford method
[31] or the modiﬁed Lowry method [32]. Other molecular biology
procedures, aswell as analysis of DNA on agarose gels or transformation
of E. coli and isolation of plasmid DNA from bacterial cells, were carried
out as described [33].
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3.1. The 500-kDa bc1 subcomplex can be rescued to the mature and
functional cytochrome bc1 complex
Recent work carried out in our laboratory has revealed the
presence of a stable bc1 core structure of about 500-kDa in yeast
mutant strains in which the gene encoding Bcs1p, Qcr9p, or ISP had
been deleted [8]. This core structure has been identiﬁed and
characterized in detail analyzing the digitonin-solubilized mitochon-
drial membranes from the corresponding mutant yeast strains
(ΔBCS1, ΔQCR9, ΔISP) by two-dimensional BN–PAGE/SDS–PAGE.
The minimal composition of this 500-kDa bc1 subcomplex was
found in the ΔQCR9 strain: it consisted of the two catalytic subunits
cytochrome b and cytochrome c1, and the supernumerary subunits
core protein 1 and 2, Qcr6p, Qcr7p, and Qcr8p [8]. Interestingly, this
bc1 subcomplex also contained the chaperone Bcs1p. The lack of
maturation of the 500-kDa bc1 subcomplex was due to the absence of
Qcr9p that was necessary for the binding of ISP which, in its turn, was
essential for the binding of Qr10p [8]. On the other hand, in the ΔBCS1
strain, we found a bc1 subcomplex of similar size because the absenceFig. 1. Complementation of the ΔBCS1 deletion yeast strain with wild type Bcs1p. In panel A
medium to the exponential growth phase (OD578 of 1–2). Afterwards, the cells were separat
medium containing galactose 2% wt./vol., instead of glucose. Transferring cells from glucose-
transcription to be induced. Recombinant cells were then harvested at 4 h after induction.
strains were solubilized with 1% digitonin and analyzed by BN–PAGE, as described in Materia
speciﬁc for core protein 1 and core protein 2. In panel B, the mitochondrial membranes from
after BN–PAGE in the ﬁrst dimension. The gel was blotted and probed with antibodies again
cytochrome c oxidase complex.of Bcs1p hindered the incorporation of ISP and the subsequent
binding of Qcr10p. Interestingly, the 500-kDa bc1 subcomplex was
eventually found also in the ΔISP mutant strain in which the absence
of ISP impeded the binding of Qcr10p.
Although this 500-kDa bc1 subcomplex appears as an intermediate
during the assembly of the cytochrome bc1 complex, the possibility
that it could represent a degradation product or an incorrect product
of assembly cannot be excluded. We therefore tried to recover the
mature and functional cytochrome bc1 complex from this 500-kDa bc1
subcomplex. To this end, we expressed the S. cerevisiae Bcs1p in a
yeast mutant strain in which the gene encoding this protein had been
deleted (ΔBCS1). According to previous results [13,15], the expressed
Bcs1p was able to fully restore the levels of both ISP and Qcr10p,
thereby allowing the growth of the complemented ΔBCS1 strain on
nonfermentable carbon sources (data not shown).
We then investigated the assembly status of the cytochrome bc1
complex in theΔBCS1 strain transformedwith the plasmid expressing
the wild type yeast Bcs1p. Fig. 1A shows the 500-kDa subcomplex
found in the mitochondrial membranes from the ΔBCS1mutant strain
when solubilized with the mild detergent digitonin and analyzed by
BN–PAGE (lane 1). On the contrary, when Bcs1p was expressed in this, ΔBCS1+Bcs1p WT recombinant cells were grown overnight at 25 °C in 800 mL of YPD
ed by centrifugation, rinsed with distilled water, and cultured again for 4 h in the same
to galactose-containing medium causes the GAL1 promoter to become derepressed and
Mitochondrial membranes from wild type (WT), ΔBCS1, and ΔBCS1+Bcs1p WT yeast
ls andmethods. The protein complexes were detected by immunoblotting with antisera
the ΔBCS1+Bcs1p WT yeast strain at 4 h after induction were analyzed by SDS–PAGE
st the proteins indicated on the left side of the gel blot. Cox6bp, subunit 6b of the yeast
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concomitant appearance of three high molecular weight (MW) bands
(Fig. 1A, lane 2). These three bands showed a size similar to that of
the respiratory supercomplexes normally found in wild type yeast
mitochondria (Fig. 1A, lane 3).
We therefore analyzed further the three highMWbands present in
the ΔBCS1 strain complemented with Bcs1p (Fig. 1A, lane 2) to assess
their subunit composition. To this end, the three bands separated in
the ﬁrst dimension by BN–PAGE (Fig. 1A, lane 2) were recovered and
analyzed in the second dimension by SDS–PAGE andWestern blotting
(Fig. 1B). The three catalytic subunits (cytochrome b, cytochrome c1,
and ISP) and six of the nonredox subunits (core proteins 1 and 2,Fig. 2. Time course of bc1 assembly in the mitochondrial membranes from ΔBCS1+
Bcs1p WT yeast strain. In panel A, ΔBCS1+Bcs1p WT recombinant cells were grown
overnight at 25 °C in 800 mL of YPDmedium to the exponential growth phase (OD578 of
1–2). Afterwards, the cells were transferred in the same medium containing galactose
2% wt./vol. instead of glucose, to induce Bcs1p expression. Cells were then harvested at
0, 1, 2, and 4 h after induction of Bcs1p expression, and isolated mitochondrial
membranes were analyzed by BN–PAGE, as described in Materials and methods. The
protein complexes were detected by immunoblotting with antisera speciﬁc for core
protein 1 and core protein 2. In panel B, themitochondrial membranes isolated from the
transformed ΔBCS1 strain at progressive times of induction (0–1–2–4 h) of Bcs1p
expression were analyzed by SDS–PAGE and immunoblotted with antibodies against
Bcs1p, ISP, and Qcr10p.Qcr7p, Qcr8p, Qcr9p, and Qcr10p) were immunodetected in all the
complexes of 1000-, 850-, and 670-kDa. As already found in the wild
type yeast strain [7,8], Qcr6p, another nonredox subunit, was only
found in the 1000-kDa band. Furthermore, an antiserum directed
against the subunit Cox6b of cytochrome c oxidase reacted only with
the two high-MWbands of 1000- and 850-kDa, whereas an antiserum
directed against Bcs1p revealed the association of this protein only
with the smallest complex of 670-kDa. In perfect agreement with the
results obtainedwith wild type yeast mitochondria [7,8], the 850- and
1000-kDa bands found in the ΔBCS1+Bcs1p WT strain therefore
correspond to the homodimeric cytochrome bc1 complex plus one or
two copies of the cytochrome c oxidase complex, respectively,
whereas the 670-kDa band represents just the homodimeric bc1
complex. We can conclude that the expression of Bcs1p in the ΔBCS1
strain is able to fully restore themature and functional cytochrome bc1
complex which is then capable of forming the respiratory super-
complexes, as already found in the wild type yeast mitochondria.
The assembly status of the cytochrome bc1 complex was then
investigated in the transformed ΔBCS1 mutant strain at progressive
times of induction of Bcs1p expression. Fig. 2A shows that at the
beginning of Bcs1p expression the main band detectable was that of
500-kDa, whereas only tiny amounts of higherMWbandswere visible
(t=0 h). The band of 500-kDa progressively disappeared after 1 and
2 h of Bcs1p expression (Fig. 2A, t=1 h and 2 h). Very interestingly, a
progressive and concomitant appearance of the three high MW bands
of 670-, 850-, and 1000-kDa was clearly evident (Fig. 2A, t = 1 h and
2 h). At 4 h from the beginning of Bcs1p expression, only these three
high-MW bands were distinctly visible, with a predominance of the
1000- and 850-kDa bands over that of 670-kDa (Fig. 2A, t=4 h). At
this stage, the 500-kDa bc1 subcomplex completely disappeared
(Fig. 2A, t=4 h). Fig. 2B also reports the amounts of ISP and Qcr10p in
the transformed ΔBCS1 strain at progressive times of induction of
Bcs1p expression. The gradual expression of Bcs1p in the yeast mutant
strain lacking this chaperone protein was accompanied by a gradual
and stable expression of ISP and Qcr10p (Fig. 2B), which were
incorporated in the 500-kDa subcomplex, thereby regenerating the
respiratory chain supercomplexes, as shown in Fig. 2A. Table 2 reports
a quantiﬁcation of the protein bands shown in Fig. 2B at different
times of induction of Bcs1p expression.
In a parallel approach, we carried out a radiolabelling of cyto-
chrome b in vivo in the ΔBCS1+Bcs1p WT recombinant cells (Fig. 3).
At 0 h chase, cytochrome b was found at the position of the 500-kDa
bc1 subcomplex. Following the 1-h and 4-h chase periods and
concomitant induction of Bcs1p expression, the radioactivity found
in the 500-kDa bc1 subcomplex at t=0 h progressively disappeared in
this band and concomitantly appeared in higher MW bands
corresponding to the homodimeric bc1 and the related respiratory
supercomplexes (t=1 h and 4 h).
The main conclusion that can be drawn from these experiments is
that the 500-kDa bc1 subcomplex represents a true and productive
intermediate during the assembly of the cytochrome bc1 complex in
the inner mitochondrial membrane. These results, on the other hand,
conﬁrm that Bcs1p is required for the stable expression of ISP and
Qcr10p and for their incorporation into the cytochrome bc1 complex.Table 2
Quantiﬁcation of Bcs1p and cytochrome bc1 subunits by SDS–PAGE and Western
blotting analysis.
bc1 subunit 0 h 1 h 2 h 4 h
Bcs1p — 50 74 100
ISP 13 65 84 100
Qcr10p 26 38 65 100
The values represent the percentages of the amounts of the indicated subunits present in
theΔBCS1+Bcs1pWT yeast cells harvested and analyzed at 0, 1, 2, and 4 h after induction
of Bcs1p expression; the amounts present in this strain after 4 h were set to 100%.
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restore the mature and functional cytochrome bc1 complex
It has been reported that point mutations in different domains of
the human BCS1L lead to various biochemical defects with distinct
clinical presentations [17–24]. Because of the high similarity in the
amino acid sequence between the yeast Bcs1p and the human BCS1L
protein [13,14], the yeast Bcs1p may represent a suitable model for
investigating the essential role of speciﬁc residues for protein
function. The capability of mutated yeast Bcs1p's to recover the
mature and functional cytochrome bc1 complex from the 500-kDa bc1
subcomplex (bc1 core structure) was then investigated.
The amino acid sequence of the yeast Bcs1p includes three
different domains with speciﬁc functions, as illustrated in Fig. 4. The
ﬁrst domain (residues 1–126) is involved in the targeting and sorting
of the protein into the inner mitochondrial membrane. This domain
includes an N-terminal tail localized in the intermembrane space
(residues 1–44), a short transmembrane domain (residues 45–68), a
positively charged segment in the form of an amphipathic α-helix
(residues 69–83) essential for targeting [34] and eventually an import
auxiliary region (residues 84–126) [35]. The second domain (residues
127–218) is structurally speciﬁc for Bcs1p but its precise function is
still unknown. The third domain (residues 219–456) is the AAA
domain that allows Bcs1p to bind and hydrolyze ATP during its
chaperone activity.Fig. 3. Incorporation of the in vivo radiolabelled cytochrome b into the mature bc1
complex and the respiratory supercomplexes following Bcs1p expression. For in vivo
labelling of mitochondrial translation products, ΔBCS1+Bcs1p WT recombinant cells
were grown in the minimal medium YNB-U and then incubated with 0.2 mg/mL
cycloheximide for 2.5 min at 30 °C, to inhibit cytoplasmic protein synthesis. Pulse
labelling was performed by the addition of 40 μCi [35S] methionine/cysteine for 15 min
at 30 °C, followed by the addition of cold methionine to a ﬁnal concentration of 4 mM.
Cells were ﬁnally harvested (0 h) or resuspended in the minimal medium YNB-U
containing galactose 2% wt./vol. for extended chase times (1–4 h) and concomitant
induction of Bcs1p expression. Finally, recombinant cells were analyzed by BN–PAGE, as
described in Fig. 1A and visualized by ﬂuorography.We introduced some speciﬁc point mutations in the yeast Bcs1p on
the basis of the correspondingmutations found in the human ortholog
BCS1L protein. The ﬁrst one, R45C in human BCS1L [20] and R81C in
the yeast ortholog (this study), is located in the amphipathic α-helix
critical for the import of the newly synthesized protein into
mitochondria. The second mutation, R155P in human BCS1L [19]
and K192P in the yeast ortholog (this study), is instead positioned in
the second domain of the chaperone protein, the so-called Bcs1p
speciﬁc domain. The third mutation analyzed, F368I in human BCS1L
[21] and F401I in the yeast ortholog (this study), is located in the third
domain, the AAA domain. All these three amino acid changes found in
human BCS1L caused severe cytochrome bc1 complex deﬁciencies in
patients, as previously reported [19–21].
First of all, we checked whether each of the mutated yeast Bcs1p's
was able to restore the mitochondrial respiratory functionality when
expressed in the ΔBCS1 strain. Fig. 5A shows that this yeast deletion
strain complemented with the yeast R81C Bcs1p had growth
properties on nonfermentable carbon sources comparable to those
of the ΔBCS1 strain complemented with the wild type Bcs1p. Fur-
thermore, this phenotype was not temperature-sensitive (Fig. 5A). In
separate experiments, we also determined the doubling time for a
wild type yeast strain (W303), for the ΔBCS1 strain complemented
either with thewild type Bcs1p orwith the R81C Bcs1p. The calculated
doubling times (about 3 hours) were practically identical for all three
yeast strains (data not shown). These results suggest that the R81C
mutation in the yeast protein is relatively innocuous. On the contrary,
the K192P and the F401I yeast Bcs1p's failed to restore the respiratory
growth of the ΔBCS1 mutant strain (Fig. 5A). These results were
conﬁrmed when the mitochondrial membranes isolated from the
ΔBCS1 strain transformed with the corresponding plasmids expres-
sing the mutated Bcs1p's (R81C, K192P, F401I) were analyzed by BN–
PAGE. Fig. 5B, lane 1, shows that the R81C Bcs1p expressed in the
ΔBCS1 strain was able to recover some high-MW bands with sizes
similar to those of the respiratory supercomplexes shown in Fig. 1A.
On the contrary, when the K192P or the F401I Bcs1p's were expressed
in the ΔBCS1 strain, a lower MW band of about 500-kDa was es-
sentially visible (Fig. 5B, lanes 2 and 3). For comparison, the bc1
subcomplex found in the ΔBCS1 strain is also shown (Fig. 5B, lane 4).
Table 3 reports the effect of Bcs1p mutations on the activity of the
cytochrome bc1 complex in the complemented ΔBCS1 strains. The
complex III activity found in the ΔBCS1 strain complemented with the
wild type Bcs1p was practically identical to that of the control yeast
strain (wild type yeast, W303). Interestingly, also the complex III
activity in the ΔBCS1 strain complemented with the R81C Bcs1p was
comparable to that of the control yeast strain, being around 90% of the
control activity. On the contrary, in the ΔBCS1 strain, as well as in the
mutant strain complemented with K192P and F401I Bcs1p's, the bc1
complex activity was completely absent.
The subunit composition of the threeprotein bands of 1000, 850, and
670-kDa found in the ΔBCS1 strain transformed with the R81C Bcs1p
(Fig. 5B, lane 1) was analyzed in the second dimension by SDS–PAGE
followed by Western blotting (data not shown). Interestingly, the
subunit composition of each protein band was identical to that found
with the expression of the wild type Bcs1p in theΔBCS1 strain (Fig. 1B).
Differently from the results found with the human BCS1L ortholog [20],
the R81C yeast protein is not only targeted tomitochondria, but it is also
able to behave like the wild type Bcs1p in its interaction with the
cytochrome bc1 complex.
The two bands of about 500-kDa identiﬁed by BN–PAGE in the
mutant strain ΔBCS1 transformed with the K192P and the F401I
Bcs1p's (Fig. 5B, lanes 2 and 3, respectively) were then analyzed in the
second dimension by SDS–PAGE and Western blotting (Fig. 6). The
molecular characterization of the two 500-kDa subcomplexes
revealed the presence of the two catalytic subunits, cytochrome
b and cytochrome c1, associated with the noncatalytic subunits core
protein 1 and 2, Qcr6p, Qcr7p, Qcr8p, and Qcr9p. No reactivity
Fig. 4. Schematic representation of the yeast Bcs1p. The three different functional domains of this protein are shown: the domain for targeting and sorting, the Bcs1p speciﬁc domain
with unknown function, and the AAA domain. This latter is highly conserved and contains a consensus sequence for ATP binding (walker A), a second motif for ATP hydrolysis
(walker B) and the arginine ﬁnger in the second region of homology (SRH). Protein Data Bank at the National Center for Biotechnology Information (NCBI) was used as reference
database to identify the structural motifs of AAA domain of Bcs1p. The red arrows indicate the positions of single point mutations obtained in this study by PCR mutagenesis.
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catalytic subunit ISP migrated as a single protein in the molecular
mass region of about 35-kDa. In addition, the antibodies directed
against Cox6bp most probably recognized the monomeric cyto-
chrome c oxidase complex migrating in the molecular mass region
of about 230-kDa. Very interestingly, bothmutant Bcs1p's (K192P and
F401I) were unable to bind this 500-kDa bc1 subcomplexes as they
were found only in a distinct 400-kDa subcomplex. It seems,
therefore, that these two mutations (K192P and F401I) abolish the
capability of Bcs1p of interacting with the 500-kDa bc1 subcomplex,
and, as a consequence, they prevent the maturation and the
functionality of the cytochrome bc1 complex.
3.3. Qcr9p or ISP overexpressed in the ΔBCS1 mutant strain were unable
to reconstruct the mature and functional cytochrome bc1 complex
It is well known that the yeast Bcs1p is essential for the in-
corporation of ISP into the cytochrome bc1 complex [8,15]. ISP, in its
turn, is essential for the binding of the last bc1 subunit, Qcr10p, and
this last event leads to the complete assembly of the homodimeric bc1
complex [8,15]. On the other hand, as previously discussed [8], the
binding of Qcr9p to the 500-kDa bc1 subcomplex precedes, and it is
necessary for the binding of ISP. Therefore, the presence of both
Qcr9p and Bcs1p is essential for ISP incorporation into the 500-kDa
bc1 subcomplex. It appears, however, that Bcs1p and Qcr9p work
independently, in the sense that neither can substitute for the other
in ISP recruitment into the bc1 subcomplex [8]. Interestingly, in theTable 3







The activities are expressed as percentages of the bc1 complex activity measured in
mitochondrial membranes isolated from the wild type strain (1.3 μmol cytochrome c
reduced/min/mg protein). This valuewas set at 100%. The data represent themean±SD
for three experiments.
a Reduction of cytochrome c was measured at 550 nm with reduced decylubiquinol
(DBH2) as substrate. Speciﬁc activity is calculated asmicromoles of cytochrome c reduced
per minute per milligram of protein with an extinction coefﬁcient of 19.6/mM/cm.subunit analysis of the 500-kDa bc1 subcomplex found in the ΔBCS1
strain, a certain decrease in the amount of Qcr9p was clearly evident
(data not shown). This ﬁnding, together with the fact that Qcr9p, as
well as Bcs1p, is necessary for ISP binding, prompted us to investigate
the effect of an overexpression of Qcr9p in the ΔBCS1 strain. Fig. 7A
shows that the ΔBCS1 strain in which Qcr9p has been overexpressed
was still respiratory-deﬁcient. Accordingly, the BN–PAGE analysis of
the mitochondrial membranes isolated from this strain (ΔBCS1+
Qcr9p) revealed only the presence of the 500-kDa bc1 subcomplex
(Fig. 7B, lane 2). A similar experiment, in which the catalytic subunit
ISP was overexpressed in the ΔBCS1 strain, was then carried out. As
expected, the overexpression of ISP in the yeast mutant strain in
which Bcs1p was absent was not able to recover the respiratory
growth of the cells (Fig. 7A) or the assembly of the mature and
functional bc1 complex (Fig. 7B, lane 3).
In a parallel approach, we cotransformed the ΔBCS1 strain with
vectors expressing, on the onehand, both ISP andK192PBcs1por, on the
other hand, both ISP and F401I Bcs1p. Also in these conditions, the
coexpression of both proteins was not able to rescue the respiratory
deﬁciency of the ΔBCS1 strain (Fig. 7A) or to reconstruct the
homodimeric bc1 complex and the related respiratory supercomplexes
(Fig. 7B, lanes 4 and 5).
4. Discussion
Although many important results have been obtained in the ﬁeld of
assembly of multisubunit complexes of the mitochondrial respiratory
chain [8,36–38], a comprehensive and clear picture of the molecular
mechanisms involved in this process is still missing. A collateral and
promising topic is that regarding the association occurring between
distinct respiratory complexes to form the mitochondrial supercom-
plexes and the respiratory strings [5,6,8,39–41]. And, even more
exciting, is the ﬁnding of an interaction between the respiratory
complexes and the protein import machinery of mitochondria [42] or
the inﬂuence of the ATP synthase on the assembly state of the
respiratory supercomplexes [43]. It is generally accepted, and it is
frankly obvious, that all these complicated events require the
participation of ancillary proteins which mediate processes of folding,
unfolding, assembly, and degradation tomaintain a steady-state level of
assembled and functional respiratory complexes.
The current data available for the cytochrome bc1 complex
assembly indicate that distinct subcomplexes exist and may co-
operate with each other in the construction of the homodimeric bc1
Fig. 5. Effect of three point mutations in the yeast Bcs1p on cytochrome bc1 complex assembly and mitochondrial functionality. In panel A, the ΔBCS1 strain transformed with
mutated BCS1 genes producing the indicated mutant proteins (R81C; K192P; F401I) and the control strains ΔBCS1+Bcs1p WT were serially diluted, starting with 1×105 cells and
grown on fermentable (YPD) and respiratory (YPEG) plates at 30 and 37 °C. In panel B, mitochondrial membranes isolated from the ΔBCS1+R81C Bcs1p, ΔBCS1+K192P Bcs1p, and
ΔBCS1+F401I Bcs1p yeast strains after 4 h of induction of Bcs1p expression were analyzed by BN–PAGE, as described in Fig. 1A. For comparison, the 500-kDa bc1 subcomplex found
in the ΔBCS1 strain is also shown.
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discovery of a bc1 structural core in the inner mitochondrial
membrane, having a molecular mass of about 500-kDa [8].
No direct evidence, however, exists that these bc1 subcomplexes
represent real intermediates during the assembly of the cytochrome
bc1 complex into the inner mitochondrial membrane. In the present
study, we clearly demonstrate that it is possible to fully reconstruct
the homodimeric and functional cytochrome bc1 complex from the
bc1 structural core of about 500-kDa.
For this purpose, we used the ΔBCS1 yeast strain in which the gene
encoding the chaperone Bcs1p was deleted. The progressive expres-
sion of Bcs1p in the ΔBCS1 strain gradually converted the 500-kDa
band to a higher MW band (670-kDa) corresponding to the
homodimeric bc1 and eventually to the respiratory supercomplexes
of 850- and 1000-kDa (Fig. 2A). A pulse and chase experiment carried
out with the in vivo radiolabelled cytochrome b traced the passage of
this protein from the 500-kDa bc1 subcomplex to the mature bc1
complex and to the respiratory supercomplexes upon Bcs1p expres-
sion (Fig. 3). Accordingly, the complemented ΔBCS1 strain after 4 h of
induction of Bcs1p expression became fully respiratory-competent
like the wild type yeast strain W303. On the contrary, the over-
expression of either Qrc9p or ISP in the ΔBCS1 mutant strain was
unable to reconstruct the cytochrome bc1 complex and to recover its
respiratory phenotype (Fig. 7). As far as we know, this is the ﬁrst timethat a direct evidence of an in vivo assembly of the cytochrome bc1
complex is shown.
In addition, we investigated the effect of speciﬁc amino acid
substitutions in the yeast Bcs1p on the cytochrome bc1 assembly in
yeast mitochondria. Interestingly, a recent structural–functional
analysis carried out in several yeast Bcs1p mutants has revealed the
fundamental role played by some amino acid residues in distinct
domains of this chaperone [44]. In the present study, the starting
point for the design of the yeast Bcs1p mutations was a survey of the
literature on the recent identiﬁed human BCS1L mutations [17–24].
Up to now, more than 20 different amino acid substitutions, or other
kinds of sequence alterations such as premature termination, have
been found in the human ortholog BCS1L.
We decided to mutate three speciﬁc amino acid residues in the
yeast Bcs1p, one for each of the three chaperone domains. The ﬁrst
mutation, R81C, is present in an amphipathic α-helix where, together
with other basic residues, constitutes a targeting signal recognized by
the protein import machinery of yeast mitochondria [34,35]. This
arginine is phylogenetically conserved in human, mouse, S. cerevisae,
Caenorhabditis elegans, and Drosophila melanogaster. Notably, the
substitution of this arginine with cysteine in human BCS1L (R45C) is
the cause of a severe defect in cytochrome bc1 complex function [20].
It is quite obvious to speculate that an alteration of the targeting
signal of human BCS1L prevents its import into mitochondria and,
Fig. 6. Resolution of mitochondrial membranes from ΔBCS1+K192P Bcs1p and ΔBCS1+F401I Bcs1p yeast strains by BN–PAGE and SDS–PAGE. Mitochondrial membranes from
ΔBCS1+K192P Bcs1p and ΔBCS1+F401I Bcs1p yeast strains were ﬁrstly analyzed by BN–PAGE and then by SDS–PAGE in the second dimension. The gel was blotted and probed
with antibodies to the proteins indicated on the left side of the gel blot.
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Surprisingly, our results show that the yeast R81C Bcs1p, when
expressed in the mutant ΔBCS1 yeast cells, is able to fully rescue the
immature cytochrome bc1 complex found in these cells and to restore
the normal respiratory phenotype. Although this may be due to the
expression of the R81C Bcs1p from a high copy plasmid, a more likely
explanation is that the arginine in position 81 is not essential for
Bcs1p targeting to yeast mitochondria. This assumption is conﬁrmed
by the presence of the mutated protein in the mitochondrial
membranes isolated from the complemented yeast strain (ΔBCS1+
R81C Bcs1p). A possible explanation of this ﬁnding could be related to
the fact that only a few amino acid identities are found between this
internal targeting sequence of the yeast polypeptide and the
corresponding amino acid stretch of the human sequence. It is
therefore possible that different, or partially different, mechanisms of
protein targeting exist between yeast Bcs1p and human BCS1L, even if
these proteins show a common domain organization and a high
sequence identity.
The mutation K192P destroyed the capability of yeast Bcs1p to
reconstruct the mature and functional cytochrome bc1 complex when
expressed in the ΔBCS1 mutant strain. The corresponding mutation in
human BCS1L (R155P) was pathogenic and responsible for severe bc1
complex deﬁciency [19]. It is also interesting to underline that the yeast
K192P Bcs1pwas not able to bind the 500-kDa bc1 subcomplex found in
theΔBCS1mutant strain. This suggests that this amino acid substitution,
located in the second domain, causes a profound alteration in the
protein structure, therebyhindering thebindingof themutatedBcs1p to
the immature bc1 complex.Whether the lysine inposition192 is directly
involved in binding or whether the amino acid substitution induces ageneral alteration of Bcs1p folding which, in its turn, decreases the
binding, is currently unknownandmerits future investigations. In fact, it
is important to remember that the function of this region remains to be
characterized and could potentially explain the observed pathogenicity
of this amino acid mutation.
The last mutation F401I was also unable to recover the functional
cytochrome bc1 complex in the ΔBCS1 mutant yeast mitochondria.
Furthermore, the corresponding mutation in human BCSL1 (F368I)
was highly pathogenic [21]. No crystal structure for the yeast Bcs1p is
currently available. Nevertheless, a theoretical three-dimensional
model of the AAA domain of yeast Bcs1p has been constructed on
the basis of existing structures of othermembers of this protein family
[44]. On the basis of this model, the F401I mutation should be located
in the C-terminal subdomain closing the nucleotide-binding site. It
is therefore even more surprising that the F401I yeast Bcs1p was
unable to bind the 500-kDa bc1 subcomplex. An explanation for this
result could be related to the fact that Bcs1p exists in the form of
oligomers in its free state and the passage to the bound form probably
requires the hydrolysis of ATP. In fact, in the mitochondrial
membranes isolated from the ΔBCS1 strain complemented with the
F401I Bcs1p, this mutated protein was found in an aggregated form of
about 400-kDa not bound to the 500-kDa bc1 subcomplex (Fig. 6).
Interestingly, this oligomeric form of about 400-kDa was also found in
the case of the K192P Bcs1p which was also unable to rescue the 500-
kDa bc1 subcomplex in the ΔBCS1 strain (Fig. 6).
We believe that the results reported in the present study give new
insights into the molecular mechanisms involved in cytochrome bc1
complex assembly and open up new avenues of investigation
especially in the late steps of assembly in which Bcs1p is actively
Fig. 7. Overexpression of Qcr9p or ISP in the ΔBCS1 deletion yeast strain. In panel A, serial dilutions of the ΔBCS1 strain transformed with vector expressing wild type yeast Bcs1p or
Qcr9p or ISP (ΔBCS1+Bcs1p WT, ΔBCS1+Qcr9p, and ΔBCS1+ISP) were grown on fermentable (YPD) and respiratory (YPEG) plates at 30 and 37 °C. In addition, serial dilutions of
the ΔBCS1 strain cotransformed with vector expressing both ISP and K192P Bcs1p or both ISP and F401I Bcs1p were grown on fermentable (YPD) and respiratory (YPEG) plates at 30
and 37 °C. In Panel B, mitochondrial membranes from the ΔBCS1 and from the ΔBCS1+Qcr9p, ΔBCS1+ISP, ΔBCS1+ISP+K192P Bcs1p, and the BCS1+ISP+F401I Bcs1p yeast
strains after 4 h of induction of expression were analyzed by BN–PAGE, as described in Fig. 1A.
100 L. Conte et al. / Biochimica et Biophysica Acta 1813 (2011) 91–101involved. The clariﬁcation of the role of Bcs1p is particularly
interesting in view of the severe human pathologies deriving from
its malfunctioning.
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